Skip to content
sellModerate cluster of 610b5-1 plan

Tate Michael Truett sold $36M of ALAB

Chief Financial Officer at Astera Labs, Inc.. 334,000 shares at an average of $108.15, traded Dec 2, 2024, filed Dec 4, 2024.

Warning score
47
Value
$36M
334,000 shares
Holdings after
1,428,888
-19% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001736297-24-000061, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 2, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-24,077$101.62$2.4M1,738,811Dec 4, 2024
Dec 2, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-55,003$102.59$5.6M1,683,808Dec 4, 2024
Dec 2, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-84,220$103.49$8.7M1,599,588Dec 4, 2024
Dec 2, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-3,700$104.44$386k1,595,888Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-1,185$105.80$125k1,594,703Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-1,600$107.08$171k1,593,103Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-1,180$108.16$128k1,591,923Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-4,575$109.58$501k1,587,348Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-21,670$110.52$2.4M1,565,678Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-19,793$111.32$2.2M1,545,885Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-27,905$112.53$3.1M1,517,980Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-18,489$113.54$2.1M1,499,491Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-19,804$114.54$2.3M1,479,687Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-25,978$115.71$3.0M1,453,709Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-23,222$116.46$2.7M1,430,487Dec 4, 2024
Dec 3, 2024SOpen-market sale
Common Stockindirect: By Tate Trust10b5-1
-1,599$117.10$187k1,428,888Dec 4, 2024

Related signals

Other insiders at Astera Labs, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
25Weaksell10b5-1ALAB
Astera Labs, Inc.
Dyckerhoff Stefan A
director
$4.7M12,499
35Weaksell 510b5-1ALAB
Astera Labs, Inc.
ALBA MANUEL
director
$1.3M11,000
42Moderatesell 510b5-1ALAB
Astera Labs, Inc.
Tate Michael Truett
Chief Financial Officer
$1.9M16,000
45Moderatesell 610b5-1ALAB
Astera Labs, Inc.
ALBA MANUEL
director
$14M126,000
45Moderatesell 710b5-1ALAB
Astera Labs, Inc.
HURLSTON MICHAEL E.
director
$6.7M67,453
45Moderatesell 710b5-1ALAB
Astera Labs, Inc.
Mohan Jitendra
Chief Executive Officer
$19M173,366
60Notablesell 7ALAB
Astera Labs, Inc.
Dyckerhoff Stefan A
director
$4.9M45,629
45Moderatesell 810b5-1ALAB
Astera Labs, Inc.
Mohan Jitendra
Chief Executive Officer
$18M171,064
75Notablesell 8ALAB
Astera Labs, Inc.
Dyckerhoff Stefan A
director
$18M203,445
57Moderatesell 8ALAB
Astera Labs, Inc.
Tate Michael Truett
Chief Financial Officer
$672k7,398

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.